DTIL

#3503
Precision BioSciences, Inc. Common Stock
4.20
+7.42%
Setor:
Base:
Moeda do lucro:
Faixa diária
4.20
4.20
Faixa anual
3.53
8.82
Mudança diária
+7.42%
Mudança mensal
+2.94%
Mudança em 6 meses
-16.67%
Mudança anual
-22.22%
Fechamento anterior
3.91
Open
4.20
Bid
Ask
Low
4.20
High
4.20
Volume
5
Open full chart

Financials

Overview Relatórios Statistics Dividends
Quarterly Annual
Income statement Balance sheet Cash flow
Value Q3, 24Q4, 24Q1, 25Q2, 25Q3, 25 TTM

Precision BioSciences Inc

Precision BioSciences, Inc. is a publicly traded American clinical stage gene editing company headquartered in Durham, North Carolina. Founded in 2006, Precision is focused on developing both in vivo and ex vivo gene editing therapies using its proprietary "ARCUS" genome editing platform.

Notícias